ADIL - Adial Pharmaceuticals, Inc.
(NaN%)
We couldn't determine Recommendation based on the data we have.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Adial Pharmaceuticals, Inc. (ADIL) - http://www.adialpharma.com
Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson in November 2010 and is headquartered in Charlottesville, VA.Exchange - NASDAQ
Industry - Pharmaceuticals: Major
Sector - Health Technology
CEO - William B. Stilley
Employees - 4
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.
Know the Stock © 2021 and future.